The Moscone Center
San Francisco, California, United States
1 - 6 February 2020
Conference 11241
Biophotonics and Immune Responses XV
Monday 3 February 2020
This conference is no longer accepting submissions.
Late submissions may be considered subject to chair approval. For more information, please contact Dawn Jackson.
show | hide
Abstract Due:
24 July 2019

Author Notification:
30 September 2019

Manuscript Due Date:
8 January 2020

show | hide
Conference Chair
  • Wei R. Chen, Univ. of Central Oklahoma (United States)

Program Committee
  • Sandra O. Gollnick, Roswell Park Comprehensive Cancer Ctr. (United States)
  • Michael R. Hamblin, Wellman Ctr. for Photomedicine (United States)
  • Tomas Hode, Immunophotonics, Inc. (United States)
  • Yih-Chih Hsu, Chung Yuan Christian Univ. (Taiwan)
  • Mladen Korbelik, BC Cancer Research Ctr. (Canada)
  • Hong Liu, The Univ. of Oklahoma (United States)
  • Mark F. Naylor, Dermatology Associates of San Antonio (United States)

Program Committee continued...
Call for
Immunological responses are crucial in the treatment of diseases. Phototherapy (photothermal, photochemical, and photomechanical), often used in conjunction with immunotherapy, has shown promise in stimulating and enhancing host immune systems. Recently, many researchers have started human clinical studies using photo-immunotherapy. This conference will provide a forum for discussion and interaction among people from academia, industry, and health professions who are working in this area. It will serve as a bridge between technology development and clinical applications, in the field of phototherapy-related immune activities.

This conference will focus on induction, enhancement, mechanisms, and detection of immune responses induced by phototherapy and combination modalities. It will specifically address the issue of searching for an effective immunological modality for different diseases, ranging from autoimmune diseases to cancer, using optical methods. It will also address the issue of detecting immune activities, using modern technologies such as molecular and cellular imaging, as well as other imaging modalities. It will include research using different combinations of treatment and detection modalities, novel approaches for stimulations of systemic responses, innovative methods in monitoring and guiding photo-immunotherapy, and immunological responses related to nanotechnology-based phototherapeutics and diagnosis.

Preliminary session topics include:
  • immunophotonics in diagnostics and therapeutics
  • novel technologies in monitoring immune activities
  • novel combination therapy in cancer treatment
  • new approaches in inducing immune responses
  • local and systemic effects of low intensity laser irradiation
  • local and systemic effects of high intensity laser irradiation
  • sensing and sensors for immune activities
  • molecular imaging for immune responses
  • in vitro and in vivo cellular and biomolecular responses
  • photodynamic therapy and immune responses
  • photoimmunotherapy in clinical applications
  • light-induced vaccination.
Back to Top